BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16732332)

  • 1. LHX6 is a sensitive methylation marker in head and neck carcinomas.
    Estécio MR; Youssef EM; Rahal P; Fukuyama EE; Góis-Filho JF; Maniglia JV; Goloni-Bertollo EM; Issa JP; Tajara EH
    Oncogene; 2006 Aug; 25(36):5018-26. PubMed ID: 16732332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
    Olasz J; Juhász A; Remenár E; Engi H; Bak M; Csuka O; Kásler M
    Oncol Rep; 2007 Jul; 18(1):105-12. PubMed ID: 17549354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
    Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
    Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma.
    Lv Z; Zhang M; Bi J; Xu F; Hu S; Wen J
    Am J Clin Pathol; 2006 May; 125(5):740-6. PubMed ID: 16707376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas.
    Martone T; Gillio-Tos A; De Marco L; Fiano V; Maule M; Cavalot A; Garzaro M; Merletti F; Cortesina G
    Clin Cancer Res; 2007 Sep; 13(17):5089-94. PubMed ID: 17785562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of RAD17 in head and neck cancer.
    Zhao M; Begum S; Ha PK; Westra W; Califano J
    Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
    Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
    Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
    Tokumaru Y; Yamashita K; Osada M; Nomoto S; Sun DI; Xiao Y; Hoque MO; Westra WH; Califano JA; Sidransky D
    Cancer Res; 2004 Sep; 64(17):5982-7. PubMed ID: 15342377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma.
    Hsiung DT; Marsit CJ; Houseman EA; Eddy K; Furniss CS; McClean MD; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):108-14. PubMed ID: 17220338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble CD44 is a potential marker for the early detection of head and neck cancer.
    Franzmann EJ; Reategui EP; Pedroso F; Pernas FG; Karakullukcu BM; Carraway KL; Hamilton K; Singal R; Goodwin WJ
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1348-55. PubMed ID: 17627000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR.
    Gonzalgo ML; Liang G; Spruck CH; Zingg JM; Rideout WM; Jones PA
    Cancer Res; 1997 Feb; 57(4):594-9. PubMed ID: 9044832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma.
    Chang HW; Ling GS; Wei WI; Yuen AP
    Cancer; 2004 Jul; 101(1):125-32. PubMed ID: 15221997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOH at chromosome 9q34.3 and the Notch1 gene methylation are less involved in oral squamous cell carcinomas.
    Gao S; Krogdahl A; Eiberg H; Liu CJ; Sørensen JA
    J Oral Pathol Med; 2007 Mar; 36(3):173-6. PubMed ID: 17305639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.